Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 1729135, 10 pages
http://dx.doi.org/10.1155/2016/1729135
Research Article

Proapoptotic Role of Potassium Ions in Liver Cells

1Third Clinical Medical School of Southern Medical University, Guangzhou 510515, China
2Department of General Surgery, The Second People’s Hospital of Guangdong Province, Southern Medical University, Guangzhou 510515, China
3Department of Gastrointestinal Surgery, The Affiliated Hospital, Youjiang Medical University for Nationalities, Guangxi 533000, China
4Department of Vascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
5Laboratory Medicine, The Second People’s Hospital of Guangdong Province, Southern Medical University, Guangzhou 510515, China

Received 8 November 2015; Revised 29 December 2015; Accepted 7 February 2016

Academic Editor: Kallesh D. Jayappa

Copyright © 2016 Zhenglin Xia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Urrego, A. P. Tomczak, F. Zahed, W. Stühmer, and L. A. Pardo, “Potassium channels in cell cycle and cell proliferation,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 369, no. 1638, Article ID 20130094, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. T. E. DeCoursey, K. G. Chandy, S. Gupta, and M. D. Cahalan, “Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?” Nature, vol. 307, no. 5950, pp. 465–468, 1984. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Pardo and W. Stühmer, “The roles of K+ channels in cancer,” Nature Reviews Cancer, vol. 14, no. 1, pp. 39–48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Wulff, N. A. Castle, and L. A. Pardo, “Voltage-gated potassium channels as therapeutic targets,” Nature Reviews Drug Discovery, vol. 8, no. 12, pp. 982–1001, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Pillozzi, M. Masselli, E. De Lorenzo et al., “Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers,” Blood, vol. 117, no. 3, pp. 902–914, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Zhang, P. Tian, Q. Chi et al., “Human ether-à-go-go-related gene expression is essential for cisplatin to induce apoptosis in human gastric cancer,” Oncology Reports, vol. 27, no. 2, pp. 433–440, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Usman and M. K. Mathew, “Potassium channel regulator KCNRG regulates surface expression of Shaker-type potassium channels,” Biochemical and Biophysical Research Communications, vol. 391, no. 3, pp. 1301–1305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Brevet, D. Fucks, D. Chatelain et al., “Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of kv1.3 gene promoter methylation,” Pancreas, vol. 38, no. 6, pp. 649–654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Sciaccaluga, B. Fioretti, L. Catacuzzeno et al., “CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity,” American Journal of Physiology-Cell Physiology, vol. 299, no. 1, pp. C175–C184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA: A Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Lei, H. Liu, Y. Yang et al., “Interaction of LHBs with C53 promotes hepatocyte mitotic entry: a novel mechanism for HBV-induced hepatocellular carcinoma,” Oncology Reports, vol. 27, no. 1, pp. 151–159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Wang, H. Liu, K. Chen et al., “SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling,” Oncology Reports, vol. 28, no. 1, pp. 311–318, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Feng, H. Li, S. Liu, J. Cheng, G. Xiang, and J. Zhang, “FAM172A induces S phase arrest of HepG2 cells via Notch 3,” Oncology Reports, vol. 29, no. 3, pp. 1154–1160, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Thomadaki, A. Scorilas, C. M. Tsiapalis, and M. Havredaki, “The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner,” Cancer Chemotherapy and Pharmacology, vol. 61, no. 2, pp. 251–265, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J.-W. Jeong, C.-Y. Jin, C. Park et al., “Induction of apoptosis by cordycepin via reactive oxygen species generation in human leukemia cells,” Toxicology in Vitro, vol. 25, no. 4, pp. 817–824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Kang, J.-H. Zhang, F. Qiu, S.-I. Tashiro, S. Onodera, and T. Ikejima, “Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways,” Cancer Letters, vol. 294, no. 2, pp. 147–158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. N. Kelly and A. Strasser, “The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy,” Cell Death and Differentiation, vol. 18, no. 9, pp. 1414–1424, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Strasser, S. Cory, and J. M. Adams, “Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases,” The EMBO Journal, vol. 30, no. 18, pp. 3667–3683, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. L. Spencer and P. K. Sorger, “Measuring and modeling apoptosis in single cells,” Cell, vol. 144, no. 6, pp. 926–939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Lynam-Lennon, S. G. Maher, and J. V. Reynolds, “The roles of microRNA in cancer and apoptosis,” Biological Reviews, vol. 84, no. 1, pp. 55–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Hu and J. J. Kavanagh, “Anticancer therapy targeting the apoptotic pathway,” The Lancet Oncology, vol. 4, no. 12, pp. 721–729, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Klimatcheva and W. F. Wonderlin, “An ATP-sensitive K+ current that regulates progression through early G1 phase of the cell cycle in MCF-7 human breast cancer cells,” Journal of Membrane Biology, vol. 171, no. 1, pp. 35–46, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. D. J. Blackiston, K. A. McLaughlin, and M. Levin, “Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle,” Cell Cycle, vol. 8, no. 21, pp. 3527–3536, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Fulda, L. Galluzzi, and G. Kroemer, “Targeting mitochondria for cancer therapy,” Nature Reviews Drug Discovery, vol. 9, no. 6, pp. 447–464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Yagoda, M. von Rechenberg, E. Zaganjor et al., “RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels,” Nature, vol. 447, no. 7146, pp. 864–868, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. A. A. Marino, I. G. Iliev, M. A. Schwalke, E. Gonzalez, K. C. Marler, and C. A. Flanagan, “Association between cell membrane potential and breast cancer,” Tumor Biology, vol. 15, no. 2, pp. 82–89, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Burlacu, “Regulation of apoptosis by Bcl-2 family proteins,” Journal of Cellular and Molecular Medicine, vol. 7, no. 3, pp. 249–257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. M. C. Wei, W.-X. Zong, E. H.-Y. Cheng et al., “Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death,” Science, vol. 292, no. 5517, pp. 727–730, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Lindsay, M. D. Esposti, and A. P. Gilmore, “Bcl-2 proteins and mitochondria—specificity in membrane targeting for death,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1813, no. 4, pp. 532–539, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. L. D. Walensky, “BCL-2 in the crosshairs: tipping the balance of life and death,” Cell Death and Differentiation, vol. 13, no. 8, pp. 1339–1350, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. X.-A. Wang, S.-S. Xiang, H.-F. Li et al., “Cordycepin induces s phase arrest and apoptosis in human gallbladder cancer cells,” Molecules, vol. 19, no. 8, pp. 11350–11365, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Grills, P. V. Jithesh, J. Blayney, S.-D. Zhang, and D. A. Fennell, “Gene expression meta-analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer,” PLoS ONE, vol. 6, no. 1, Article ID e14635, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Wolf, S. Agnihotri, J. Micallef et al., “Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme,” Journal of Experimental Medicine, vol. 208, no. 2, pp. 313–326, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. G. Pastorino, N. Shulga, and J. B. Hoek, “Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis,” The Journal of Biological Chemistry, vol. 277, no. 9, pp. 7610–7618, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Chiara, D. Castellaro, O. Marin et al., “Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels,” PLoS ONE, vol. 3, no. 3, Article ID e1852, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. M. C. Shoshan, “3-bromopyruvate: targets and outcomes,” Journal of Bioenergetics and Biomembranes, vol. 44, no. 1, pp. 7–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Shoshan-Barmatz and M. Golan, “Mitochondrial VDAC1: function in cell life and death and a target for cancer therapy,” Current Medicinal Chemistry, vol. 19, no. 5, pp. 714–735, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Galluzzi, O. Kepp, N. Tajeddine, and G. Kroemer, “Disruption of the hexokinase-VDAC complex for tumor therapy,” Oncogene, vol. 27, no. 34, pp. 4633–4635, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Simamura, H. Shimada, T. Hatta, and K.-I. Hirai, “Mitochondrial voltage-dependent anion channels (VDACs) as novel pharmacological targets for anti-cancer agents,” Journal of Bioenergetics and Biomembranes, vol. 40, no. 3, pp. 213–217, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. C. Sanguinetti and M. Tristani-Firouzi, “hERG potassium channels and cardiac arrhythmia,” Nature, vol. 440, no. 7083, pp. 463–469, 2006. View at Publisher · View at Google Scholar · View at Scopus